Targeting BCL9/BCL9L enhances CD4+ T cell-mediated Th1 antitumor immunity through activation of STAT1/STAT4 signaling
Zhu Yuan-yuan, Li An-qi, Yang Fan, Dong Yu-xuan, Huang Ya-si, Meng Xiang-jing, Zhang Dai-zhou, Li Ye, Xian Yan-fang, Zhu Di, Feng Mei
Journal：ACTA PHARMACOLOGICA SINICA
IF：10.4
DOI：10.1038/s41401-026-01845-2
PMID：
Published：2026-06-29
research field：肿瘤学分子生物学细胞生物学免疫学信号转导
Abstract
本文使用的Yeasen产品
相关产品
推荐应用
